The Pharmaceutical Journal speaks about P1vital® PReDicT Test
Posted 1st February 2018

The Pharmaceutical Journal speaks about P1vital® PReDicT Test

The Pharmaceutical Journal examines personalised treatment to depression including P1vital® PReDicT Test which is being used in the PReDicT randomised clinical trial across 5 European countries.

In other news
Distractor helps you deal with lockdown trauma
Playing video games during lock down can help with mental health problems according to top neuroscientists. And it can help frontline healthcare workers deal with the traumatic scenes confronting them daily as they fight to keep COVID-19 patients alive.
3 minutes
Distractor helps you deal with lockdown trauma
Find out how i-spero® can help your patients

If you are a primary care provider, or are responsible for the purchasing/commissioning of primary care or specialist mental health services we would welcome a discussion.